Company filings profile · CIK 0001583771
Hepion Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Hepion Pharmaceuticals, Inc. (HEPA): 36 filings in the last 90 days vs 14 in the prior 90 (filing-velocity rising ↑ · 2.57×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 29, 2026. Source-linked, daily-refreshed.
Material 8-K events — Hepion Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 28, 2026 | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 27, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 20, 2026 | Departure/Election of Directors or Officers | ↗ |
| Aug 4, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | Departure/Election of Directors or Officers | ↗ |
| Jun 17, 2026 | Item 5.07 | ↗ |
Watch Hepion Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 28, 2026 | 8-K | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Sep 16, 2026 | 3 | 3 | ↗ |
| Sep 16, 2026 | SCHEDULE 13D/A | ↗ | |
| Sep 15, 2026 | SCHEDULE 13G | ↗ | |
| Sep 14, 2026 | 4 | 4 | ↗ |
| Sep 10, 2026 | DEF 14C | DEF 14C | ↗ |
| Sep 10, 2026 | 4 | 4 | ↗ |
| Sep 8, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | PRE 14C | PRE 14C | ↗ |
| Aug 27, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 3 | 3 | ↗ |
| Aug 20, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Aug 20, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 20, 2026 | SCHEDULE 13D | ↗ | |
| Aug 20, 2026 | SCHEDULE 13D | ↗ | |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 12, 2026 | 4 | 4 | ↗ |
| Aug 12, 2026 | 4 | 4 | ↗ |
| Aug 12, 2026 | 4 | 4 | ↗ |
| Aug 12, 2026 | 4 | 4 | ↗ |
| Aug 12, 2026 | 4 | 4 | ↗ |
| Aug 7, 2026 | 3 | 3 | ↗ |
| Aug 7, 2026 | S-8 | S-8 | ↗ |
| Aug 7, 2026 | SCHEDULE 13D | ↗ | |
| Aug 5, 2026 | D | Item 06b | ↗ |
| Aug 4, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 10, 2026 | 3 | 3 | ↗ |
| Jul 8, 2026 | 3 | 3 | ↗ |
| Jul 2, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Jun 17, 2026 | 8-K | Item 5.07 | ↗ |
| May 26, 2026 | 3 | 3 | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 1, 2026 | SCHEDULE 13D | ↗ |